Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.51 USD | -3.30% | +1.07% | +0.83% |
Jun. 13 | Voyager Therapeutics Names Nathan Jorgensen as Finance Chief | MT |
Jun. 13 | Voyager Therapeutics, Inc. Appoints Nathan Jorgensen as Chief Financial Officer, Effective July 8, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.83% | 463M | |
+40.80% | 53.67B | |
+35.79% | 38.86B | |
-8.05% | 38.76B | |
-8.98% | 27.27B | |
+10.69% | 25.91B | |
-16.21% | 20.29B | |
+31.00% | 12.78B | |
+28.51% | 12.18B | |
-1.67% | 11.96B |
- Stock Market
- Equities
- VYGR Stock
- News Voyager Therapeutics, Inc.
- Chardan Adjusts Price Target on Voyager Therapeutics to $6.50 From $15, Maintains Neutral Rating